- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BRCA
Total 508 results
-
AstraZenecaActive, not recruitingBreast | Prostate | Ovarian | Pancreatic | Advanced TumoursSweden, Spain, Israel, Australia, Germany
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruitingBreast Cancer | Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Life Style | Cadmium ExposureItaly
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in SituUnited States
-
North Eastern German Society of Gynaecological...Clovis Oncology, Inc.; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus...Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Clear Cell CarcinomaGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | PALB2 Gene Mutation | ATM Gene MutationUnited States
-
Kari WisinskiPfizer; Celcuity IncActive, not recruitingTNBC - Triple-Negative Breast CancerUnited States
-
AtlasMedx, IncorporatedActive, not recruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Homologous Recombination Deficiency | Advanced Malignant NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Syndrome | BRCA2 Syndrome | No Evidence of Disease | Hereditary Ovarian Carcinoma | Hereditary Female Breast CarcinomaUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.Active, not recruitingBreast Cancer Metastatic | BRCA 1 Gene Mutation | BRCA 2 Gene MutationItaly, Spain, United States, Czechia, Romania, France, Korea, Republic of, United Kingdom, Hungary, Japan, Peru, Poland, Russian Federation, Turkey, China, Taiwan, Bulgaria, Switzerland, Mexico
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingObesity | Overweight | Ductal Breast Carcinoma In Situ | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Premalignant LesionUnited States
-
The Netherlands Cancer InstituteActive, not recruitingBreast CancerNetherlands, France
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHereditary Breast and Ovarian Cancer Syndrome | Premenopausal | Deleterious BARD1 Gene Mutation | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Deleterious BRIP1 Gene Mutation | Deleterious EPCAM Gene Mutation | Deleterious MLH1 Gene Mutation | Deleterious MSH2 Gene Mutation | Deleterious... and other conditionsUnited States
-
Hamilton Health Sciences CorporationCompleted
-
Sidekick HealthLandspitali University Hospital; Ljósið Cancer Rehabilitation CenterActive, not recruiting
-
AstraZenecaCompletedOvarian CancerCanada, Czechia, Poland, Romania, United States, Belgium, France, Russian Federation, United Kingdom, Israel, Spain, Germany, Austria, Netherlands, Australia, Estonia, Ukraine
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteAstraZeneca; Cyclacel Pharmaceuticals, Inc.Active, not recruiting
-
University of UtahClovis Oncology, Inc.Terminated
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative...United States
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingFatigue | Overweight | Lynch Syndrome | Chronic Lymphocytic Leukemia | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Breast Carcinoma | Cancer Survivor | Ovarian Carcinoma | Health Status Unknown | Body Mass Index 25 or GreaterUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
AbbVieCompletedMetastatic Breast CancerUnited States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Netherlands, Norway, Po... and more
-
European Organisation for Research and Treatment...AstraZenecaWithdrawnBRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
-
Cancer Trials IrelandActive, not recruitingFallopian Tube Cancer | Primary Peritoneal Carcinoma | Serous Ovarian Tumor | Endometrioid Carcinoma OvaryIreland
-
AstraZenecaCompletedOvarian Neoplasms | BRCA1 Protein | BRCA2 ProteinNetherlands, Belgium, United Kingdom, Poland
-
UNICANCERCompletedLetrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation (LIBER)Breast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierFrance
-
Beth Israel Deaconess Medical CenterJohns Hopkins University; Dana-Farber Cancer Institute; AstraZenecaActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | Somatic Mutation Breast Cancer (BRCA1) | Somatic Mutation Breast Cancer (BRCA2)United States
-
Roswell Park Cancer InstituteAstraZenecaActive, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Serous AdenocarcinomaUnited States
-
MedSIRGlaxoSmithKlineCompletedBreast Cancer | Breast Cancer MetastaticSpain
-
Dana-Farber Cancer InstituteActive, not recruiting
-
UNICANCERARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research GroupActive, not recruitingER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI StatusFrance
-
Institut CurieCompletedWomen With BRCA1 Germline Deleterious MutationFrance
-
Spanish Lung Cancer GroupTerminatedNon Small Cell Lung Cancer | BRCA1 MutationSpain
-
University of WashingtonActive, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Castration-Resistant Prostate Carcinoma | Homologous Recombination Deficiency | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | ATM Gene Mutation | Prostate Carcinoma Metastatic in the Bone | PSA Level Greater...United States
-
University of OxfordAstraZenecaCompletedOvarian CancerUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedBreast NeoplasmsSweden, United States, United Kingdom, Germany, Spain, Australia, Israel, Canada
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnUveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Recurrent Metastatic MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Primary Peritoneal High Grade Serous Adenocarcinoma | Stage III Fallopian Tube Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage III Primary Peritoneal Cancer AJCC v8 | Stage IIIA Fallopian Tube Cancer AJCC v8 | Stage IIIA Ovarian Cancer AJCC v8 | Stage... and other conditionsUnited States
-
New Mexico Cancer Care AllianceActive, not recruitingPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...AstraZenecaActive, not recruitingMetastatic Pancreatic AdenocarcinomaFrance
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
Aspira Women's HealthTerminatedHereditary Breast and Ovarian Cancer | Adnexal Mass | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene MutationUnited States
-
AstraZenecaCompletedAdvanced Solid TumorsUnited States, Spain
-
HKGepitherapeuticsKazakh Research Institute of Oncology & Radiology; Montreal EpiTerapia Inc.; Canada-Kazakhstan...TerminatedBreast Cancer | Breast Cancer FemaleKazakhstan